A Phase II, Randomized, Double-Blind, Placebo-Controlled Bronchoscopy Study to Evaluate the Effects of Lebrikizumab on Airway Eosinophilic Inflammation in Patients with Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication

Project: Research project

Project Details

StatusFinished
Effective start/end date2/13/15 → 2/13/18

Funding

  • Quintiles, Inc. (Prot #GB29260 // Prot #GB29260)
  • Genentech, Inc (Prot #GB29260 // Prot #GB29260)